Literature DB >> 10400560

[Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916].

G Guillain, J A Barré, A Strohl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400560

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


× No keyword cloud information.
  22 in total

1.  [ON A POLYRADICULONEURITIC SYNDROME WITH PROGRESSIVE PARALYSIS IN 3 GENERATIONS OF A FAMILY].

Authors:  G PAAL; D BOEHME; G KRICKAU
Journal:  Arch Psychiatr Nervenkr       Date:  1963-12-03

2.  [TROPHIC TRACHEOTOMY COMPLICATIONS IN GUILLAIN-BARRE POLYRADICULITIS].

Authors: 
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1964-11-25

3.  Variants of Guillain-Barré syndrome: low incidence but high impact.

Authors:  Helmar C Lehmann; Hans-Peter Hartung
Journal:  J Neurol       Date:  2009-07-25       Impact factor: 4.849

Review 4.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

Review 5.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

6.  Clinical presentations as predictors of prolonged mechanical ventilation in Guillain-Barré syndrome in an institution with limited medical resources.

Authors:  Umarudee Toamad; Chanon Kongkamol; Suwanna Setthawatcharawanich; Kitti Limapichat; Kanitpong Phabphal; Pornchai Sathirapanya
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

7.  Guillain-Barré Syndrome.

Authors:  Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

Review 8.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

Review 9.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 10.  Immunotherapy in Peripheral Neuropathies.

Authors:  Jean-Marc Léger; Raquel Guimarães-Costa; Cristina Muntean
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.